Clinical Trial: A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621159) titled 'A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer' on May 27.

Brief Summary: This is a phase Ib/II clinical study. All participants are patients with advanced colorectal cancer (CRC). The purpose of this study is to to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary anti-tumor efficacy of HDM2017 in combination with standard of care in patients with advanced CRC.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer Metastatic

Intervention: DRUG: HDM2017

Following a predefined dose and date.

DRUG: Fruquintinib

Foll...